Overview
HL-60 cells are a type of human leukemic cell line that has been widely used in basic and applied research in hematology, immunology, and cancer biology for over four decades. These cells were first isolated from the blood of a patient with acute promyelocytic leukemia in 1977 and have been extensively characterized since then. HL-60 cells are notable for their ability to differentiate into neutrophil-like or monocyte-like cells in response to various stimuli, which makes them a valuable model system for studying the molecular mechanisms of myeloid cell differentiation. HL-60 cells are widely used in basic research to investigate the signaling pathways and gene expression programs that regulate hematopoietic differentiation and immune response. For example, these cells have been used to study the roles of transcription factors, cytokines, growth factors, and epigenetic modifications in myeloid cell differentiation and function. Additionally, HL-60 cells have been used in drug discovery and development for leukemia and other cancers, as they can be used for high-throughput screening of potential anti-cancer agents. In conclusion, HL-60 cells are a commonly used human leukemia cell line with unique characteristics that make them well-suited to study hematopoietic differentiation and immune response. These cells have been extensively characterized and are utilized widely by researchers for both basic and applied research.